Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature-Reference-Cited by-同舟云学术

Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature

Published:2021-01-13 Issue:7 Volume:29 Page:3439-3459
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Chow Ronald^ORCID,Herrstedt Jørn,Aapro Matti,Chiu Leonard,Lam Henry,Prsic Elizabeth,Lock Michael,DeAngelis Carlo,Navari Rudolph M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-020-05935-7.pdf

Reference67 articles.

1. Cohen L, de Moor CA, Eisenberg P et al (2007)Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15:491–503

2. Pollera CF, Giannarelli D (1989) Prognostic factors influencing cisplatin-induced emesis: definition and validation of a predictive logistic model. Cancer 64:1117–1122

3. du Bois A, Meerpohl HG, Vach W et al (1992) Course, patterns and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron. Eur J Cancer 28:450–457

4. Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 15:116–123

5. Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F (2014) Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manag 47:839–848

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09

2. Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial;Journal of Clinical Oncology;2024-08-16

3. Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting;Expert Opinion on Drug Metabolism & Toxicology;2024-06-02

4. Olanzapine for chemotherapy-induced nausea and vomiting control – Authors’ reply;The Lancet Oncology;2024-05

5. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting;ESMO Open;2024-02